Drug wholesaler McKesson will pay $150 million to settle with the Justice Department allegations that it did not monitor "suspicious" opioid orders from small pharmacies, even after a 2008 agreement to do so.
Readers are full of surprises. Sometimes, stories we editors put on top of the news don’t make the cut with readers. Others are unexpected hits. Still others resurface from the past. Find all three in this year's roundup of 2016 news curated by you, our readers.
Like a modern-day Paul Revere, drug distributors McKesson and Cardinal Health are sounding a warning for the industry: price hikes are slowing, price hikes are slowing. As a result, so are their earnings.